MicroRNA-145 overexpression inhibits neuroblastoma tumorigenesis and Phospholipase D 5 (PLD5) to downregulate cell proliferation and metastasis to mitigate prostate cancer [41,42]. This evidence concerns the gene PLD5 and prostate cancer.